European Commission H2020 SME Instrument Phase 1 Grant Awarded!

We are pleased to announce that SAGA Diagnostics has been awarded the Phase 1 grant (€50,000) from the EU European Commission Horizon 2020 Program SME Instrument!  In this highly competitive commersialization program, our application was evaluated with top marks in all categories.  “Being awarded this grant is a strong signal that we are on the right track and offer compelling and innovative solutions that fit with societal needs and market demand,” says SAGA chief executive Lao Saal, adding, “I’m very proud of the entire team in helping to drive forward our mission, to improve cancer patient survival and quality of life using precision diagnostics.”